ROLE OF TRANEXAMIC ACID IN PREVENTING SEROMA FORMATION AFTER VENTRAL  HERNIA REPAIR

JM TARAR; K NADEEM; I RASHID; M NAEEM; R AHMED

doi:10.54112/bcsrj.v2023i1.211

Authors

JM TARAR Department of Thoracic Surgery, BAM & D C Multan, Pakistan
K NADEEM Department of General Surgery, Armed Forces Hospital Alhada, Taif, Kingdom of Saudi Arabia
I RASHID Department of Internal Medicine, Ahalia Hospital, United Arab Emirates
M NAEEM Department of Internal Medicine, Ibn-e-Sina Hospital Lahore, Pakistan
R AHMED Department of Biochemistry, Independent Medical College Faisalabad, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2023i1.211

Keywords:

Ventral hernia repair, Seroma formation, Tranexamic acid

Abstract

The current analysis aimed to evaluate the role of tranexamic acid in preventing seroma formation after ventral hernia repair. This cross-sectional study was conducted at Bakhtawar Amin Trust Hospital Multan from 20th Jan 2020 to 20th Jan 2021. The study included patients diagnosed with ventral hernia repair. Those with cirrhosis, strangled hernias, uncontrolled diabetes mellitus, and bleeding disorders were excluded. The volume of seroma was measured using a vacuum drain. On the fifth post-operative day, 500 mg of oral tranexamic acid was given for 12 hours, and 1gm of IV tranexamic acid was given after skin closure. Statistical significance was calculated using the Chi-square test. P-value < .05 was considered statistically significant. A total of 110 patients were included in the study. 82 (74.5%) were females, while 28 (25.5%) were male. The patients were aged 45 years. Postoperatively, in 89 patients (81%), the seroma resolved in 5 days; in 21 patients (19%), it took more than 5 days to subside. Tranexamic acid significantly reduces post-operative seroma formation in ventral hernia repair.

Downloads

Download data is not yet available.

References

Lashari A, Mirani SH, Bozdar AG, Shar ZA, Malik A. Effectiveness of Tranexamic Acid for Prevention of Post-operative Seroma Formation in Patients Undergoing Ventral Hernioplasty. Pak J Med Health Sci. 2020;14(4):1143-1145.

Cho JE, Helm MC, Helm JH, Mier N, Kastenmeier AS, Gould JC, Goldblatt MI. Retro-rectus placement of bio-absorbable mesh improves patient outcomes. Surg. Endosc. 2019;33(8):2629-2634.

Othman IH, Metwally YH, Bakr IS, Amer YA, Gaber MB, Elgohary SA. Comparative study between laparoscopic and open repair of paraumbilical hernia. J Egypt Soc Parasitol. 2012;42(1):175-182.

Purushotham G, Revanth K, Aishwarya M. Surgical management of umbilical and paraumbilical hernias. Int Surg J. 2017;24;4(8):2507-2511. doi: 10.18203/2349-2902.isj20173384

Petro CC, Haskins IN, Perez AJ, Tastaldi L, Strong AT, Ilie RN, Tu C, Krpata DM, Prabhu AS, Eghtesad B, Rosen MJ. Hernia repair in patients with chronic liver disease-A 15-year single-center experience. Am. J. Surg. 2019;217(1):59-65. doi: 10.1016/j.amjsurg.2018.10.020

Lee DU, Hastie DJ, Lee KJ, Fan GH, Addonizio EA, Kwon J, Karagozian R. The impact of compensated and decompensated cirrhosis on the post-operative outcomes of patients undergoing hernia repair: a propensity score-matched analysis of 2011–2017 US hospital database. Eur J Gastroenterol Hepatol. 2021;33(1S):e944-e953. doi: 10.1097/MEG.0000000000002321

Stansfield R, Morris D, Jesulola E. The use of tranexamic acid (TXA) for the management of hemorrhage in trauma patients in the prehospital environment: literature review and descriptive analysis of principal themes. Shock. 2020;53(3):277-283. doi: 10.1097/SHK.0000000000001389

Slattery C, Kark J, Wagner T, Verma K. The use of tranexamic acid to reduce surgical blood loss. Clin Spine Surg. 2019;32(2):46-50. doi: 10.1097/BSD.0000000000000808

Kockerling F, Simons MP. Current concepts of inguinal hernia repair. Visc Med. 2018;34(2):145-150. doi: 10.1159/000487278

Gulzar MR, Iqbal J, Haq MI, Afzal M. Darning vs bassini repair for inguinal hernia: A prospective comparative study. Prof Med J. 2007;14(01):128-133. doi: 10.29309/TPMJ/2007.14.01.3639

Seretis K, Goulis D, Demiri EC, Lykoudis EG. Prevention of seroma formation following abdominoplasty: a systematic review and meta-analysis. Aesthet Surg J. 2017;37(3):3123-3163. doi: 10.1093/asj/sjw192

Mercoli H, Tzedakis S, D'Urso A, Nedelcu M, Memeo R, Meyer N, et al. Post-operative complications as an independent risk factor for recurrence after laparoscopic ventral hernia repair: a prospective study of 417 patients with long-term follow-up. Surg. Endosc. 2017;31(3):1469-1477.

Mukherjee KA, Gunjan S, Tanusree K, Rulaniya SK, Saraf AK. Use of surgical site compression to prevent seroma formation following open inguinal hernioplasty with use of polypropylene mesh. Int J Med Health Sci. 2017;6(1):24-26.

Cherla DV, Poulose B, Prabhu AS. Epidemiology and disparities in care: the impact of socioeconomic status, gender, and race on the presentation, management, and outcomes of patients undergoing ventral hernia repair. Surg. Clin. North Am. 2018;98(3):431-440. doi: 10.1016/j.suc.2018.02.003

Ferguson DH, Smith CG, Olufajo OA, Zeineddin A, Williams M. Risk factors associated with adverse outcomes after ventral hernia repair with component separation. J Surg Res. 2020;258:299-306. doi: 10.1016/j.jss.2020.08.063

Khan R, Aalam M, Ahmed N, Pervaiz M, Saeed Z. Role of Tranexamic Acid for Seroma Prevention in Obese Patients Undergoing Laparoscopic Ventral Hernia Repair Under Spinal Anesthesia. Pak J Med Health Sci. 2021;15(10):3488-3490.

Zubair R, Mirza MR, Habib L, Iftikhar J, Zehra B. Role of tranexamic acid in prevention of seroma formation after ventral hernioplasty. Pak J Surg. 2020;36(2):126-129.

Ahmed H. Seroma reduction and role of tranexamic acid in ventral hernia repair. J Surg Pakistan. 2020;25(2):89-92. doi: 10.21699/jsp.25.2.9